Can Qi Selected Research

Neoplasms (Cancer)

1/2017	C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells.
9/2016	Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
9/2015	Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
4/2015	Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
4/2014	Expression of RABEX-5 and its clinical significance in prostate cancer.
3/2014	High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer.
1/2014	Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Can Qi Research Topics

Disease

7	Neoplasms (Cancer) 01/2017 - 01/2014
6	Prostatic Neoplasms (Prostate Cancer) 04/2014 - 08/2013
4	Carcinogenesis 09/2016 - 03/2014
3	Neuroblastoma 01/2023 - 06/2022
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 02/2015
3	Breast Neoplasms (Breast Cancer) 03/2014 - 08/2013
2	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2015
2	Lymphatic Metastasis 04/2014 - 10/2013
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2014 - 10/2013
1	Reperfusion Injury 12/2023
1	Reinfection 03/2023
1	Hepatitis B 03/2023
1	Liver Diseases (Liver Disease) 03/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 07/2022
1	Lordosis 08/2020
1	Wilms Tumor (Wilm's Tumor) 09/2016
1	Genomic Instability 02/2015
1	Stomach Neoplasms (Stomach Cancer) 08/2013

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
4	NucleobindinsIBA 04/2015 - 08/2013
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2013
3	Oncogene Proteins (Oncogene Protein)IBA 09/2015 - 10/2013
3	Messenger RNA (mRNA)IBA 04/2014 - 08/2013
2	Y-Box-Binding Protein 1IBA 09/2015 - 02/2015
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2014 - 10/2013
1	6-methyladenineIBA 12/2023
1	hepatitis B hyperimmune globulinIBA 03/2023
1	entecavir FDA Link 03/2023
1	Immunoglobulins (Immunoglobulin)IBA 03/2023
1	NucleosidesIBA 03/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	AlbuminsIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2017
1	CateninsIBA 01/2017
1	Complement C1q (C1q Complement)IBA 01/2017
1	CollagenIBA 09/2016
1	Histone MethyltransferasesIBA 09/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 09/2015
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 03/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2014
1	ORALIT (ORS)IBA 11/2013
1	Staphylococcal Protein A (Protein A)IBA 10/2013

Therapy/Procedure

1	Liver Transplantation 03/2023
1	Conservative Treatment 07/2022
1	Length of Stay 08/2020
1	Therapeutics 04/2015
1	Prostatectomy (Retropubic Prostatectomy) 04/2014